ライブ
FierceBiotechGLP-1s may combat depression by multiplying a mood-boosting gut microbeEndpoints NewsSonoThera raises $125M for non-viral gene therapy approachBioPharma DiveParabilis sets a record with a $670M biotech IPOFierceBiotechBig Pharma-backed SonoThera sounds off with $125M series B for bubble-based genetic deliveryClinical OMICsGLP-1s May Benefit Mental Health Through Gut–Brain AxisClinical OMICsPhase Ib/IIa for Hepatitis B Epigenetic Silencer Shows Best-in-Class PotentialFierceBiotechEthyreal Bio manifests with $101M in pack of biotechs gunning for Amgen’s TepezzaEndpoints NewsShattuck raises $75M; Servier inks neuro ASO pact with n-Lorem FoundationEndpoints NewsBiotech pay analysis: 12 execs with $35M+ M&A golden parachutesBioPharma DiveAstraZeneca’s ‘extensive’ obesity drug push; $125M for ultrasound-aided genetic medicineFierceBiotechNovartis sticks 2nd deal with molecular glue biotech Orionis, this one worth up to $1.4BBioWorldShenzhen Chipscreen Biosciences synthesizes new HDAC inhibitors
BioWorld 2026年1月6日

Insilico inks $888M drug discovery partnership with Servier

Insilico inks $888M drug discovery partnership with Servier

原文
本文は利用できません。元の情報源をご確認ください。